These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 24695224)

  • 41. Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.
    Oksvold MP; Berglund UW; Gad H; Bai B; Stokke T; Rein ID; Pham T; Sanjiv K; Øy GF; Norum JH; Smeland EB; Myklebust JH; Helleday T; Våtsveen TK
    Sci Rep; 2021 Mar; 11(1):6317. PubMed ID: 33737576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
    Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
    Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel mechanism for preventing mutations caused by oxidation of guanine nucleotides.
    Ishibashi T; Hayakawa H; Sekiguchi M
    EMBO Rep; 2003 May; 4(5):479-83. PubMed ID: 12717453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer.
    Fujishita T; Okamoto T; Akamine T; Takamori S; Takada K; Katsura M; Toyokawa G; Shoji F; Shimokawa M; Oda Y; Nakabeppu Y; Maehara Y
    Lung Cancer; 2017 Jul; 109():52-57. PubMed ID: 28577950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes.
    Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T
    DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes.
    Lin YT; Liu W; He Y; Wu YL; Chen WN; Lin XJ; Lin X
    Cell Physiol Biochem; 2018; 51(1):80-96. PubMed ID: 30448843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
    Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
    Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase.
    Nakabeppu Y; Oka S; Sheng Z; Tsuchimoto D; Sakumi K
    Mutat Res; 2010 Nov; 703(1):51-8. PubMed ID: 20542142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MTH1 Inhibitor TH588 Disturbs Mitotic Progression and Induces Mitosis-Dependent Accumulation of Genomic 8-oxodG.
    Rudd SG; Gad H; Sanjiv K; Amaral N; Hagenkort A; Groth P; Ström CE; Mortusewicz O; Berglund UW; Helleday T
    Cancer Res; 2020 Sep; 80(17):3530-3541. PubMed ID: 32312836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue.
    McPherson LA; Troccoli CI; Ji D; Bowles AE; Gardiner ML; Mohsen MG; Nagathihalli NS; Nguyen DM; Robbins DJ; Merchant NB; Kool ET; Rai P; Ford JM
    DNA Repair (Amst); 2019 Nov; 83():102644. PubMed ID: 31311767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of micronucleus induction in MTH1 knockdown cells exposed to UVA, UVB or UVC.
    Fotouhi A; Cornella N; Ramezani M; Wojcik A; Haghdoost S
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():161-5. PubMed ID: 26520386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MTH1 inhibition synergizes with ROS-inducing agents to trigger cervical cancer cells undergoing parthanatos.
    Li C; Xue Y; Wu J; Zhang L; Yang T; Ai M; Han J; Zheng X; Wang R; Boldogh I; Ba X
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167190. PubMed ID: 38657912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sanitation enzymes: Exquisite surveillance of the noncanonical nucleotide pool to safeguard the genetic blueprint.
    Broderick K; Moutaoufik MT; Aly KA; Babu M
    Semin Cancer Biol; 2023 Sep; 94():11-20. PubMed ID: 37211293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MTH1 Inhibitors for the Treatment of Psoriasis.
    Bivik Eding C; Köhler I; Verma D; Sjögren F; Bamberg C; Karsten S; Pham T; Scobie M; Helleday T; Warpman Berglund U; Enerbäck C
    J Invest Dermatol; 2021 Aug; 141(8):2037-2048.e4. PubMed ID: 33676948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer.
    Taiyab A; Choudhury A; Haidar S; Yousuf M; Rathi A; Koul P; Chakrabarty A; Islam A; Shamsi A; Hassan MI
    Biomed Pharmacother; 2024 Apr; 173():116332. PubMed ID: 38430630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of As3mt and Mth1 in the genotoxic and carcinogenic effects induced by long-term exposures to arsenic in MEF cells.
    Barguilla I; Peremartí J; Bach J; Marcos R; Hernández A
    Toxicol Appl Pharmacol; 2020 Dec; 409():115303. PubMed ID: 33141059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The druggability of intracellular nucleotide-degrading enzymes.
    Rampazzo C; Tozzi MG; Dumontet C; Jordheim LP
    Cancer Chemother Pharmacol; 2016 May; 77(5):883-93. PubMed ID: 26614508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathways controlling dNTP pools to maintain genome stability.
    Rudd SG; Valerie NCK; Helleday T
    DNA Repair (Amst); 2016 Aug; 44():193-204. PubMed ID: 27311542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Double-Edged Sword: The Anti-Cancer Effects of Emodin by Inhibiting the Redox-Protective Protein MTH1 and Augmenting ROS in NSCLC.
    Wahi D; Soni D; Grover A
    J Cancer; 2021; 12(3):652-681. PubMed ID: 33403025
    [No Abstract]   [Full Text] [Related]  

  • 60. Protonation states of Asp residues in the human Nudix hydrolase MTH1 contribute to its broad substrate recognition.
    Nakamura T; Koga-Ogawa Y; Fujimiya K; Chirifu M; Goto M; Ikemizu S; Nakabeppu Y; Yamagata Y
    FEBS Lett; 2023 Jul; 597(13):1770-1778. PubMed ID: 36914375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.